Category Covid-19

PIER MARIA FORNASARI
2021-04-07

Guidance produced from the Expert Haematology Panel of British Society for Haematology focussed on syndrome of Thrombosis and Thrombocytopenia occurring after coronavirus Vaccination

An expert team of British Society for Haematology have recently been involved in diagnosing and managing a rare syndrome of thrombosis associated with low platelets which have been reported in a few cases. At the moment, any causal association with coronavirus vaccination has not been established. However, are identified patients with this syndrome in proximity

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2021-04-06

Ranking Virus Spillover Risk: New Web App Ranks Spillover Risk for Newly Detected Viruses

SARS-CoV-2 showed the world with devastating clarity the threat undetected viruses can pose to global public health. SpillOver, a new web application developed by scientists at the University of California, Davis, and contributed to by experts from all over the world, ranks the risk of wildlife-to-human spillover for newly discovered viruses. SpillOver is the first open-source risk

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2021-04-05

Recovered and vaccinated patients T cells recognize recent SARS-CoV-2 variants

NIH research suggests protective effects of vaccination remain intact When variants of SARS-CoV-2 (the virus that causes COVID-19) emerged in late 2020, concern arose that they might elude protective immune responses generated by prior infection or vaccination, potentially making re-infection more likely or vaccination less effective. To investigate this possibility, researchers from the National Institute

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2021-04-04

Study underscores need for multidisciplinary care for COVID-19 long-haulers

Long COVID can affect multiple organ systems and the most common symptoms include fatigue, shortness of breath, brain fog, anxiety, depression, and post-traumatic stress disorder (PTSD) Based on the limited data available, at least one-third of patients hospitalized for COVID-19 studied to date have experienced such long-term effects Physicians across the country have analyzed the

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2021-04-03

Globally Accessible Therapy Is Found to Protect Against Lethal Inflammation from COVID-19 in Animal Models

Mount Sinai researchers have found that a widely available and inexpensive drug targeting inflammatory genes has reduced morbidity and mortality in mice infected with SARS-CoV-2, the virus that causes COVID-19. In a study published today in the journal Cell, the team reported that the drug, Topotecan (TPT), inhibited the expression of inflammatory genes in the lungs

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2021-03-25

Individual SARS-CoV-2 neutralising antibody immunity lasts from days to decades. Patients were categorized in 5 groups: negative, rapid waining, slow waining, persistent and delayed response.

Study shows that antibody longevity varies widely from 40 days to as long as several decades and not everyone who has recovered from COVID-19 is immune from reinfection  Individuals with low levels of neutralising antibodies may still be protected if they have robust T-cell immunity Blood tests and a computer algorithm suggest annual vaccinations might

Read More

No Comments InCovid-19